|
CH389134A
(de)
|
1960-03-15 |
1965-03-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Anthrachinonküpenfarbstoffe
|
|
NL293572A
(enExample)
|
1962-06-07 |
|
|
|
|
CH478818A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
|
FR1593586A
(enExample)
|
1967-10-17 |
1970-06-01 |
|
|
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
|
CH560197A5
(en)
|
1971-05-17 |
1975-03-27 |
Ciba Geigy Ag |
2-alkylthio-4,6-bis (subst amino)-5-nitropyrimidines - - herbicides
|
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
|
CH574206A5
(enExample)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
|
CH584739A5
(enExample)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
|
FR2258841B1
(enExample)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
|
AT327605B
(de)
|
1974-05-06 |
1976-02-10 |
Ciba Geigy Ag |
Mittel zur hemmung des pflanzenwachstums
|
|
AU492126B2
(en)
|
1974-05-14 |
1975-11-20 |
Ciba-Geigy Ag |
Nitropyrimidine derivatives
|
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
|
WO1981003174A1
(fr)
|
1980-04-28 |
1981-11-12 |
Teijin Ltd |
Derives de thiazolo (3,2-a) pyrimidine, leur procede de preparation, et medicaments les contenant
|
|
EP0053678A1
(de)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide
|
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
|
JPS6157587A
(ja)
|
1984-08-29 |
1986-03-24 |
Shionogi & Co Ltd |
縮合複素環誘導体および抗潰瘍剤
|
|
PH22302A
(en)
|
1985-02-11 |
1988-07-22 |
Fujisawa Pharmaceutical Co |
Piperidine compounds
|
|
AU601145B2
(en)
|
1985-03-01 |
1990-09-06 |
Duphar International Research B.V. |
Benzoyl urea derivatives having anti-tumor activity
|
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
|
CA1340284C
(en)
|
1987-03-19 |
1998-12-22 |
Zeneca Inc. |
Herbicidal substituted cyclic diones
|
|
EP0324426B1
(en)
|
1988-01-11 |
1996-06-19 |
Fuji Photo Film Co., Ltd. |
Process for forming super high contrast negative images
|
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
|
NZ238863A
(en)
|
1990-07-19 |
1993-03-26 |
Janssen Pharmaceutica Nv |
Substituted thiazolyl and pyridinyl derivatives
|
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
|
EP0567643A4
(en)
|
1991-01-16 |
1995-07-19 |
Yoshitomi Pharmaceutical |
NEW PYRIDE DERIVATIVE AND ITS USE AS A SELECTIVE MEDICINAL PRODUCT.
|
|
CA2070978A1
(en)
|
1991-06-11 |
1992-12-12 |
William J. Greenlee |
Cyclic renin inhibitors
|
|
GB9114760D0
(en)
|
1991-07-09 |
1991-08-28 |
Pfizer Ltd |
Therapeutic agents
|
|
JPH0533359A
(ja)
|
1991-08-02 |
1993-02-09 |
Kubota Corp |
全旋回型の小型バツクホウ
|
|
EP0556889A1
(en)
|
1992-02-18 |
1993-08-25 |
Duphar International Research B.V |
Method of preparing aryl(homo)piperazines
|
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
|
TW237456B
(enExample)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
NZ314207A
(en)
|
1992-09-28 |
2000-12-22 |
Vertex Pharma |
1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
|
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
TW444018B
(en)
|
1992-12-17 |
2001-07-01 |
Pfizer |
Pyrazolopyrimidines
|
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
|
JPH0753546A
(ja)
|
1993-08-09 |
1995-02-28 |
Kuraray Co Ltd |
ジアリール置換複素環化合物およびその医薬用途
|
|
HUT74464A
(en)
|
1993-10-12 |
1996-12-30 |
Du Pont Merck Pharma |
1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
|
|
GB9400889D0
(en)
|
1994-01-18 |
1994-03-16 |
Sandoz Ltd |
Novel compounds
|
|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
EP0781766B1
(en)
|
1994-09-09 |
2004-03-31 |
Nippon Shinyaku Company, Limited |
Heterocyclic derivative and medicine
|
|
PL181963B1
(pl)
|
1994-11-29 |
2001-10-31 |
Dainippon Pharmaceutical Co |
Nowe pochodne indolu, kompozycja farmaceutyczna zawierajaca nowe pochodne indolu oraz sposób wytwarzania nowych pochodnych indolu PL PL PL
|
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
EP0813525B9
(en)
|
1995-03-10 |
2004-02-04 |
Berlex Laboratories, Inc. |
Benzamidine derivatives their preparation and their use as anti-coagulants
|
|
IL117659A
(en)
|
1995-04-13 |
2000-12-06 |
Dainippon Pharmaceutical Co |
Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
WO1996033994A1
(en)
|
1995-04-28 |
1996-10-31 |
Nippon Soda Co., Ltd. |
Amino-substituted derivatives, process for the preparation thereof, and herbicide
|
|
DE69603240T2
(de)
|
1995-05-12 |
2000-01-05 |
Neurogen Corp., Branford |
Neue deazapurinderivate; eine neue klasse von crf1-spezifischen liganden
|
|
WO1996036613A1
(en)
|
1995-05-19 |
1996-11-21 |
Nippon Soda Co., Ltd. |
Substituted benzoic acid derivatives, process for the production thereof, and herbicides
|
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
|
JP2000507911A
(ja)
|
1995-08-31 |
2000-06-27 |
ロンザ アーゲー |
ジヒドロキシピリミジン誘導体の製造方法
|
|
HUP9802318A3
(en)
|
1995-10-26 |
2001-04-28 |
Mitsubishi Tokyo Pharm Inc |
Phenylethanolamine derivatives, process for producing the same, and intermediates in the production of the same
|
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
|
USH2007H1
(en)
|
1996-01-19 |
2001-12-04 |
Fmc Corporation |
Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
|
|
DE19602095A1
(de)
|
1996-01-22 |
1997-07-24 |
Bayer Ag |
Halogenpyrimidine
|
|
AU708055B2
(en)
|
1996-02-02 |
1999-07-29 |
Merck & Co., Inc. |
Heterocyclic derivatives as antidiabetic and antiobesity agents
|
|
CZ244598A3
(cs)
|
1996-02-07 |
1998-10-14 |
Janssen Pharmaceutica N.V. |
Pyrazolopyrimidiny jako antagonisty CRF receptoru
|
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
AU3176297A
(en)
|
1996-06-25 |
1998-01-14 |
Novartis Ag |
Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
|
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
|
AU735401B2
(en)
|
1996-08-28 |
2001-07-05 |
Pfizer Inc. |
Substituted 6,5-hetero-bicyclic derivatives
|
|
DK0929547T3
(da)
|
1996-09-12 |
2003-03-10 |
Schering Ag |
Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
|
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
CA2229123A1
(en)
|
1997-02-11 |
1998-08-11 |
Mitchell Irvin Steinberg |
Pharmaceutical agents
|
|
AU6279598A
(en)
|
1997-02-18 |
1998-09-08 |
Neurocrine Biosciences, Inc. |
Biazacyclic CRF antagonists
|
|
DK0977737T3
(da)
|
1997-04-22 |
2004-01-26 |
Janssen Pharmaceutica Nv |
CRF-antagonistisk quino- og quinazoline
|
|
AU751710B2
(en)
|
1997-04-22 |
2002-08-22 |
Neurocrine Biosciences Inc. |
CRF antagonistic thiophenopyridines
|
|
JPH11193277A
(ja)
|
1997-05-14 |
1999-07-21 |
Nippon Soda Co Ltd |
ピリミジン誘導体、その製法および有害生物防除剤
|
|
IL134002A0
(en)
|
1997-08-14 |
2001-04-30 |
Bayer Ag |
Methoximinomethyloxadiazines used as pesticides
|
|
DE19737723A1
(de)
|
1997-08-14 |
1999-02-18 |
Bayer Ag |
Methoximinomethyloxadiazine
|
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
|
CN1062110C
(zh)
|
1997-09-19 |
2001-02-21 |
山东工程学院 |
带式钵苗喂入机构
|
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
AU3378799A
(en)
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted pyrrolo(2,3-b)pyridine and pyrrolo(2,3-d)pyrimidine derivatives: modulators of crf1 receptors
|
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
|
WO2000011003A1
(en)
|
1998-08-21 |
2000-03-02 |
Du Pont Pharmaceuticals Company |
ISOXAZOLO[4,5-d]PYRIMIDINES AS CRF ANTAGONISTS
|
|
PL204427B1
(pl)
|
1998-11-10 |
2010-01-29 |
Janssen Pharmaceutica Nv |
Hamująca replikację wirusa HIV pochodna pirymidyny, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
NZ511087A
(en)
|
1998-11-20 |
2004-01-30 |
Arena Pharm Inc |
Human orphan G protein-coupled receptors
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
WO2000035875A1
(en)
|
1998-12-17 |
2000-06-22 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
|
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
|
CZ20012006A3
(cs)
|
1998-12-18 |
2002-03-13 |
Axys Pharmaceuticals, Inc. |
Sloučenina a farmaceutický prostředek
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
DE60010448T2
(de)
|
1999-03-17 |
2005-04-07 |
Astrazeneca Ab |
Amid-derivate
|
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
KR100709498B1
(ko)
|
1999-04-28 |
2007-04-20 |
사노피-아벤티스 도이칠란트 게엠베하 |
Ｐｐａｒ 수용체 리간드로서의 디아릴 산 유도체
|
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
CA2385747A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Pyrazolopyrimidines as therapeutic agents
|
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
|
EP1225874B1
(en)
|
1999-09-24 |
2006-02-01 |
Janssen Pharmaceutica N.V. |
Antiviral solid dispersions
|
|
CZ20021086A3
(cs)
|
1999-09-30 |
2002-10-16 |
Neurogen Corporation |
Alkylendiaminem substituované heterocykly
|
|
KR20020047198A
(ko)
|
1999-09-30 |
2002-06-21 |
해피 페너 ; 해리 에이치. 페너 2세 |
특정 알킬렌 디아민-치환된피라졸로[1,5-ａ]-1,5-피리미딘 및피라졸로[1,5-ａ]-1,3,5-트리아진
|
|
CN1377355A
(zh)
|
1999-09-30 |
2002-10-30 |
纽罗杰有限公司 |
氨基取代的吡唑并[1,5－a]－1,5－嘧啶和吡唑并[1,5－a]－1,3,5－三嗪
|
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
|
AU2335801A
(en)
|
1999-12-22 |
2001-07-03 |
Merck Frosst Canada & Co. |
Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
|
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
|
IL150337A0
(en)
|
1999-12-30 |
2002-12-01 |
Lundbeck & Co As H |
Phenylpiperazinyl derivatives
|
|
EA200200688A1
(ru)
|
2000-01-18 |
2003-02-27 |
Пфайзер Продактс Инк. |
Антагонисты фактора, высвобождающего кортикотропин
|
|
HUP0204474A3
(en)
|
2000-02-09 |
2004-07-28 |
Hokuriku Pharmaceutical |
1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
|
|
WO2001060870A1
(en)
|
2000-02-15 |
2001-08-23 |
Foster Miller, Inc. |
No voc radiation curable resin compositions
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
|
EP1261327B1
(en)
|
2000-02-25 |
2005-04-27 |
F.Hoffmann-La Roche Ag |
Adenosine receptor modulators
|
|
RU2298418C2
(ru)
|
2000-04-12 |
2007-05-10 |
Новартис Аг |
Комбинация по меньшей мере двух соединений, выбранных из групп антагонистов at1-рецептора или ингибиторов асе (ангиотензинпревращающий фермент), или ингибиторов hmg-coa-редуктазы (бета-гидрокси-бета-метилглутарил-кофермент-а-редуктаза)
|
|
US7034019B2
(en)
|
2000-05-08 |
2006-04-25 |
Janssen Pharmaceutica N.V. |
Prodrugs of HIV replication inhibiting pyrimidines
|
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
|
WO2001087892A1
(en)
|
2000-05-18 |
2001-11-22 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists
|
|
WO2001087929A2
(en)
|
2000-05-18 |
2001-11-22 |
Bayer Aktiengesellschaft |
Regulation of human dopamine-like g protein-coupled receptor
|
|
AU6031001A
(en)
|
2000-05-25 |
2001-12-03 |
Hoffmann La Roche |
Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
JP2004501191A
(ja)
|
2000-06-28 |
2004-01-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
カルベジロール
|
|
CN1705649A
(zh)
|
2000-06-29 |
2005-12-07 |
艾伯特公司 |
芳基苯基杂环基硫醚衍生物及其作为抑制细胞粘附的抗炎和免疫抑制剂的用途
|
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
|
MXPA03000436A
(es)
|
2000-07-18 |
2003-06-24 |
Yamanouchi Pharma Co Ltd |
Medicamentos que compreden derivados de dicianopiridina.
|
|
ATE362468T1
(de)
|
2000-07-25 |
2007-06-15 |
Merck & Co Inc |
N-substituierte indole mit anwendung in der behandlung von diabetes
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
WO2002019975A1
(fr)
|
2000-09-05 |
2002-03-14 |
Taisho Pharmaceutical Co., Ltd. |
Stimulants de la croissance des cheveux
|
|
ATE367802T1
(de)
|
2000-09-20 |
2007-08-15 |
Jagotec Ag |
Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
|
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
|
WO2002032408A2
(en)
|
2000-10-20 |
2002-04-25 |
Novartis Ag |
Combinations of a thyromimetic compound and a statin
|
|
ES2372028T3
(es)
|
2000-10-23 |
2012-01-13 |
Glaxosmithkline Llc |
Nuevo compuesto de 8h-pirido[2,3-d]pirimidin-7-ona trisustituida para el tratamiento de enfermedades mediadas por la csbp/p38 quinasa.
|
|
WO2002060434A2
(en)
|
2000-10-31 |
2002-08-08 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
|
WO2002040480A2
(en)
|
2000-11-03 |
2002-05-23 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists and methods relating thereto
|
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
|
AU2002223492A1
(en)
|
2000-11-14 |
2002-05-27 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
|
EP1340749A4
(en)
|
2000-11-17 |
2007-09-05 |
Takeda Pharmaceutical |
ISOXAZOLE DERIVATIVES
|
|
CA2448729A1
(en)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Piperazinyl and piperidyl substituted heterocyclic compounds
|
|
AU2002218509A1
(en)
|
2000-12-01 |
2002-06-11 |
Yamanouchi Pharmaceutical Co..Ltd. |
Method of screening remedy for diabetes
|
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
|
ES2257461T3
(es)
|
2000-12-21 |
2006-08-01 |
Bristol-Myers Squibb Company |
Inhibidores de tiazolilo de tirosina quinasas de la familia tec.
|
|
NZ526532A
(en)
|
2001-01-26 |
2005-01-28 |
Schering Corp |
The use of substituted azetidinone compounds for the treatment of sitosterolemia
|
|
US7064217B2
(en)
|
2001-01-30 |
2006-06-20 |
University Of Virginia Patent Foundation |
Agonists and antagonists of sphingosine-1-phosphate receptors
|
|
CA2434491A1
(en)
|
2001-01-30 |
2002-08-08 |
Merck & Co., Inc. |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
|
|
BR0207302A
(pt)
|
2001-02-08 |
2004-02-10 |
Memory Pharm Corp |
Trifluorometilpurinas como inibidores da fosfodiesterase 4
|
|
JP2004521124A
(ja)
|
2001-02-09 |
2004-07-15 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病および脂質障害用の２−アリールオキシ−２−アリールアルカン酸類
|
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
|
WO2002072101A1
(en)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
A corticotropin releasing factor receptor ligand, its enantiomer and pharmaceutically acceptable salts
|
|
US7534547B2
(en)
|
2001-03-29 |
2009-05-19 |
Osaka Gas Company Limited |
Optically active compound and photosensitive resin composition
|
|
WO2002081454A1
(en)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
PL367297A1
(en)
|
2001-04-20 |
2005-02-21 |
Wyeth |
Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
WO2002092068A1
(en)
|
2001-05-10 |
2002-11-21 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
|
PT1397351E
(pt)
|
2001-06-01 |
2010-01-04 |
Hoffmann La Roche |
Derivados de pirimidina, triazina e pirazina como receptores de glutamato
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
EP1406875B1
(en)
|
2001-06-26 |
2013-07-31 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of tnf-alpha expression
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2003026661A1
(fr)
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
|
BRPI0212894B8
(pt)
|
2001-09-27 |
2021-05-25 |
Kyorin Seiyaku Kk |
composto ou sal do mesmo farmaceuticamente aceitável e composição farmacêutica
|
|
EP1438048A1
(en)
|
2001-10-18 |
2004-07-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
|
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1461069A2
(en)
|
2001-12-29 |
2004-09-29 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
|
US20050043315A1
(en)
|
2002-01-02 |
2005-02-24 |
Hideo Tsutsumi |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
|
WO2003061567A2
(en)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
AU2003207567B2
(en)
|
2002-01-18 |
2008-01-24 |
Merck Sharp & Dohme Corp. |
Edg receptor agonists
|
|
EP1467729A1
(en)
|
2002-01-18 |
2004-10-20 |
The Genetics Company Inc. |
Beta-secretase inhibitors
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
EP1482896A4
(en)
|
2002-03-01 |
2005-11-23 |
Merck & Co Inc |
AMINO ALKYL PHOSPHONATES AND RELATED COMPOUNDS AS EDG RECEPTOR AGONISTS
|
|
AU2003228283A1
(en)
|
2002-03-07 |
2003-09-22 |
X-Ceptor Therapeutics, Inc. |
Quinazolinone modulators of nuclear receptors
|
|
CN1642422A
(zh)
|
2002-03-15 |
2005-07-20 |
西巴特殊化学品控股有限公司 |
4－氨基嘧啶及其在表面抗菌处理中的应用
|
|
AR039090A1
(es)
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
|
WO2003088962A1
(en)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|
|
WO2003087064A1
(en)
|
2002-04-18 |
2003-10-23 |
Ucb, S.A. |
Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
|
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
|
WO2003094845A2
(en)
|
2002-05-08 |
2003-11-20 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
JP4831965B2
(ja)
|
2002-06-10 |
2011-12-07 |
エラン ファーマ インターナショナル，リミティド |
ＨＭＧ−ＣｏＡ還元酵素インヒビター誘導体（「スタチン」）を含むナノ粒子製剤、その新規組合せ、ならびにこれらの医薬組成物の製造
|
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
|
WO2003103632A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
WO2003103633A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate sterol formulations and sterol combinations
|
|
WO2003105763A2
(en)
|
2002-06-14 |
2003-12-24 |
Amylin Pharmaceuticals, Inc. |
Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof
|
|
WO2003105771A2
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
|
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
US20060014717A1
(en)
|
2002-06-28 |
2006-01-19 |
Glykos Finland Oy |
Therapeutic compositions for use in prophylaxis or treatment of diarrheas
|
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
|
US20060004010A1
(en)
|
2002-07-10 |
2006-01-05 |
Hiromu Habashita |
Ccr4 antagonist and medical use thereof
|
|
US20050267133A1
(en)
|
2002-07-23 |
2005-12-01 |
Brown Matthew L |
Pyrazolopyrimidines as kinase inhibitors
|
|
WO2004009602A1
(en)
|
2002-07-23 |
2004-01-29 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
|
WO2004009597A2
(en)
|
2002-07-23 |
2004-01-29 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
US20060105445A1
(en)
|
2002-07-29 |
2006-05-18 |
Klaus Godl |
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins
|
|
US7297715B2
(en)
|
2002-07-30 |
2007-11-20 |
Merck & Co., Inc. |
PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
|
|
DE60322075D1
(de)
|
2002-07-30 |
2008-08-21 |
Merck & Co Inc |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
|
WO2004010949A2
(en)
|
2002-07-30 |
2004-02-05 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
|
JP2004067575A
(ja)
|
2002-08-06 |
2004-03-04 |
Yaizu Suisankagaku Industry Co Ltd |
糖尿病治療薬効果促進剤
|
|
AU2003264047B2
(en)
|
2002-08-08 |
2008-06-26 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
|
JP2006500378A
(ja)
|
2002-08-21 |
2006-01-05 |
メルク エンド カムパニー インコーポレーテッド |
二元ＰＰＡＲα／γアゴニストとアンギオテンシンＩＩのＩ型受容体アンタゴニストを使用する併用療法
|
|
BR0313825A
(pt)
|
2002-08-29 |
2005-07-12 |
Merck & Co Inc |
Composto, composição farmacêutica, método para tratar de diabete mellitus tipo 2 em um mamìfero, e, uso de composto
|
|
WO2004019869A2
(en)
|
2002-08-29 |
2004-03-11 |
Merck & Co., Inc. |
Indoles having anti-diabetic activity
|
|
US20050191612A1
(en)
|
2002-09-11 |
2005-09-01 |
Takahide Ohishi |
Method of screening insulin content enhancer
|
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
|
WO2004033710A2
(en)
|
2002-10-09 |
2004-04-22 |
Genaissance Pharmaceuticals, Inc. |
Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
|
|
JP2006504755A
(ja)
|
2002-10-15 |
2006-02-09 |
スミスクライン ビーチャム コーポレーション |
Ｇｓｋ−３阻害薬としてのピリダジン化合物
|
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
|
WO2004041164A2
(en)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Kinase inhibitors
|
|
EP1559422B1
(en)
|
2002-11-08 |
2014-04-30 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
|
JP4516430B2
(ja)
|
2002-12-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
１−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
|
|
US7714004B2
(en)
|
2002-12-20 |
2010-05-11 |
Bayer Pharmaceuticals Corporation |
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
|
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
|
PL377847A1
(pl)
|
2003-01-14 |
2006-02-20 |
Arena Pharmaceuticals Inc. |
1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia
|
|
ATE359782T1
(de)
|
2003-01-16 |
2007-05-15 |
Sb Pharmco Inc |
Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
|
|
AU2004207444B2
(en)
|
2003-01-17 |
2008-07-31 |
Merck & Co., Inc. |
N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
|
|
EP1594508B1
(en)
|
2003-02-11 |
2012-08-08 |
Irm Llc |
Novel bicyclic compounds and compositions
|
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
|
SI1602660T1
(sl)
|
2003-02-18 |
2011-06-30 |
Kyorin Seiyaku Kk |
Derivati aminofosfonske kisline, njihove adicijske soli in modulatorji receptorja za S1P
|
|
EP1606282B1
(en)
|
2003-02-24 |
2008-11-12 |
Arena Pharmaceuticals, Inc. |
Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
|
|
JP2004269469A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
|
JP2004269468A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
|
EA200501376A1
(ru)
|
2003-03-28 |
2006-04-28 |
Пфайзер Продактс Инк. |
Производные 1,2,4-замещённых 1,2,3,4-тетрагидро- и 1,2-дигидрохинолинов и 1,2,3,4-тетрагидрохиноксалина в качестве ингибиторов сетр для лечения атеросклероза и тучности
|
|
ES2392167T3
(es)
|
2003-04-30 |
2012-12-05 |
Novartis Ag |
Derivados aminopropanol como moduladores del receptor esfingosina-1-fosfato
|
|
JP2006525366A
(ja)
|
2003-04-30 |
2006-11-09 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環式カルボン酸置換基
|
|
ATE547395T1
(de)
|
2003-04-30 |
2012-03-15 |
Novartis Pharma Gmbh |
Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors
|
|
TWI393560B
(zh)
|
2003-05-02 |
2013-04-21 |
Japan Tobacco Inc |
包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
|
|
ATE475421T1
(de)
|
2003-05-06 |
2010-08-15 |
Ustav Ex Botan Akademie Ved Ce |
Pyrazoloä4,3-düpyrimidines, verfahren zur ihre herstellung und deren verwendung
|
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2004240586A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
|
CN1791395B
(zh)
|
2003-05-19 |
2012-09-26 |
Irm责任有限公司 |
免疫抑制剂化合物及组合物
|
|
ES2467160T3
(es)
|
2003-05-19 |
2014-06-12 |
Irm Llc |
Compuestos y composiciones inmunosupresores
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
EP1644367B1
(en)
|
2003-05-19 |
2015-10-14 |
Novartis AG |
Immunosuppressant compounds and compositions
|
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
|
WO2004110368A2
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Combination therapy for the treatment of hypertension
|
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
EP1661879A4
(en)
|
2003-08-04 |
2006-11-29 |
Ono Pharmaceutical Co |
A DIPHENYL ETHER COMPOUND, PROCESS FOR THE PRODUCTION AND USE THEREOF
|
|
PL2287156T3
(pl)
|
2003-08-15 |
2013-11-29 |
Novartis Ag |
2,4-Di(fenyloamino)-pirymidyny stosowane w leczeniu chorób nowotworowych, chorób zapalnych i zaburzeń układu immunologicznego
|
|
US20050043327A1
(en)
|
2003-08-21 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
|
US7528120B2
(en)
|
2003-08-28 |
2009-05-05 |
Novartis Ag |
Aminopropanol derivatives
|
|
CN101407471A
(zh)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
|
JP4947406B2
(ja)
|
2003-08-29 |
2012-06-06 |
小野薬品工業株式会社 |
Ｓ１ｐ受容体結合能を有する化合物およびその医薬用途
|
|
WO2005020920A2
(en)
|
2003-09-02 |
2005-03-10 |
Merck & Co., Inc. |
Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
US7732442B2
(en)
|
2003-09-05 |
2010-06-08 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
|
PE20050374A1
(es)
|
2003-09-05 |
2005-05-30 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc
|
|
EP1697342A2
(en)
|
2003-09-08 |
2006-09-06 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2005026148A1
(en)
|
2003-09-08 |
2005-03-24 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
AR046330A1
(es)
|
2003-09-09 |
2005-12-07 |
Japan Tobacco Inc |
Inhibidor de dipeptidilpeptidasa iv
|
|
EP1667683A4
(en)
|
2003-09-23 |
2009-04-29 |
Merck & Co Inc |
QUINOLINE POTASSIUM CHANNEL INHIBITORS
|
|
WO2005030127A2
(en)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
EP1670463A2
(en)
|
2003-10-01 |
2006-06-21 |
Merck & Co., Inc. |
3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
WO2005037215A2
(en)
|
2003-10-14 |
2005-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for enhancing cognitive function and synaptic plasticity
|
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
|
WO2005041899A2
(en)
|
2003-11-03 |
2005-05-12 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
|
TW200528106A
(en)
|
2003-11-10 |
2005-09-01 |
Synta Pharmaceuticals Corp |
Pyridine compounds
|
|
JPWO2005044780A1
(ja)
|
2003-11-10 |
2007-05-17 |
杏林製薬株式会社 |
アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
|
|
HRP20141155T1
(hr)
|
2003-11-12 |
2015-01-16 |
Sino-Med International Alliance, Inc. |
Heterocikliäśki spojevi borne kiseline
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
WO2005058315A1
(en)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
|
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
|
JP4773972B2
(ja)
|
2003-12-17 |
2011-09-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｓ１Ｐ（Ｅｄｇ）受容体作働薬としての（３，４−ジ置換）プロパンカルボン酸
|
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1711491A1
(en)
|
2003-12-24 |
2006-10-18 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
|
WO2005072530A1
(en)
|
2004-01-16 |
2005-08-11 |
Merck & Co., Inc. |
Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
|
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
AU2005212438A1
(en)
|
2004-02-11 |
2005-08-25 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
RU2332212C2
(ru)
|
2004-02-24 |
2008-08-27 |
Санкио Компани, Лимитед |
Аминоспирт
|
|
CA2553572A1
(en)
|
2004-02-24 |
2005-09-09 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
EP1726585A4
(en)
|
2004-03-05 |
2009-07-15 |
Banyu Pharma Co Ltd |
DIARYLSUBSTITUTED FIVE-GLOSS HETEROCYCLUS DERIVAT
|
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
|
CA2561632A1
(en)
|
2004-04-02 |
2005-10-20 |
Merck & Co., Inc. |
Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives
|
|
EP1764367A1
(en)
|
2004-04-12 |
2007-03-21 |
Sankyo Company, Limited |
Thienopyridine derivatives
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
EA011671B1
(ru)
|
2004-06-04 |
2009-04-28 |
Арена Фармасьютикалз, Инк. |
Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
Ｓ１ｐ受容体結合能を有する化合物およびその用途
|
|
CN101014329B
(zh)
|
2004-07-16 |
2010-09-08 |
杏林制药株式会社 |
用于对器官或组织的移植的排异反应或骨髓移植的移植物抗宿主反应预防或治疗的药物组合物
|
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
|
RU2383536C2
(ru)
|
2004-08-04 |
2010-03-10 |
Тайсо Фармасьютикал Ко., Лтд. |
Производное триазола
|
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
|
US7241812B2
(en)
|
2004-08-13 |
2007-07-10 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
|
CA2580860A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
WO2006034337A2
(en)
|
2004-09-23 |
2006-03-30 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
|
|
US7884104B2
(en)
|
2004-10-01 |
2011-02-08 |
Merck Sharp & Dohme Corp. |
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
US7557112B2
(en)
|
2004-10-08 |
2009-07-07 |
Astellas Pharma Inc. |
Aromatic-ring-fused pyrimidine derivative
|
|
EP1799217A4
(en)
|
2004-10-12 |
2008-01-23 |
Forbes Medi Tech Res Inc |
Compositions and methods for treating insulin resistance and cardiomyopathy
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
DK1650186T3
(da)
|
2004-10-22 |
2008-10-13 |
Sun Pharmaceutical Ind Ltd |
Nye dicarboxylsyrederivater
|
|
CA2583681A1
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
|
AU2005305083B2
(en)
|
2004-11-03 |
2012-02-02 |
Arena Pharmaceuticals, Inc. |
GPR41 and modulators thereof for the treatment of insulin-related disorders
|
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
|
AU2005307718A1
(en)
|
2004-11-18 |
2006-05-26 |
The Institutes For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids for the treatment of diabetes
|
|
JPWO2006057448A1
(ja)
|
2004-11-26 |
2008-06-05 |
武田薬品工業株式会社 |
アリールアルカン酸誘導体
|
|
WO2006063033A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
|
JP4318087B2
(ja)
|
2004-12-13 |
2009-08-19 |
小野薬品工業株式会社 |
アミノカルボン酸誘導体およびその医薬用途
|
|
WO2006064744A1
(ja)
|
2004-12-13 |
2006-06-22 |
Daiichi Sankyo Company, Limited |
糖尿病の治療のための医薬組成物
|
|
EP1838706A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor agonists
|
|
US20080312281A1
(en)
|
2004-12-24 |
2008-12-18 |
Matthew Colin Thor Fyfe |
G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes
|
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
|
AU2006206246A1
(en)
|
2005-01-19 |
2006-07-27 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
|
US7914859B2
(en)
|
2005-01-25 |
2011-03-29 |
Merck Patent Gmbh |
Mesogenic compounds, liquid crystal medium and liquid crystal display
|
|
EP1863463A1
(en)
|
2005-02-14 |
2007-12-12 |
University Of Virginia Patent Foundation |
Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substitued by amino and phenyl groups
|
|
JP5063581B2
(ja)
|
2005-03-23 |
2012-10-31 |
アクテリオン ファーマシューティカルズ リミテッド |
新規チオフェン誘導体
|
|
PT1863474E
(pt)
|
2005-03-23 |
2009-01-20 |
Actelion Pharmaceuticals Ltd |
Novos derivados de tiofeno como agonistas dos receptores 1 de esfingosina-1-fosfato
|
|
NZ562562A
(en)
|
2005-03-23 |
2010-11-26 |
Actelion Pharmaceuticals Ltd |
Hydrogenated benzo(C)thiophene derivatives as immunomodulators
|
|
JP2008545767A
(ja)
|
2005-06-08 |
2008-12-18 |
ノバルティス アクチエンゲゼルシャフト |
多環式オキサジアゾールまたはイソキサゾールおよびｓｉｐ受容体リガンドとしてのそれらの使用
|
|
JPWO2006132406A1
(ja)
|
2005-06-09 |
2009-01-08 |
萬有製薬株式会社 |
下痢を伴う疾患の治療剤としてのｎｐｙｙ２アゴニスト
|
|
JP2008546758A
(ja)
|
2005-06-24 |
2008-12-25 |
アクテリオン ファーマシューティカルズ リミテッド |
新規チオフェン誘導体
|
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ｐｐａｒ調節劑之醫藥組成物的用途
|
|
MX2007016545A
(es)
|
2005-06-30 |
2008-02-21 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g.
|
|
MX2007016066A
(es)
|
2005-07-01 |
2008-03-10 |
Irm Llc |
Derivados de bencimidazol sustituidos por pirimidina como inhibidores de cinasa de proteina.
|
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
|
EP1917240A1
(en)
|
2005-08-23 |
2008-05-07 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
RS20080112A
(sr)
|
2005-09-16 |
2009-05-06 |
Arena Pharmaceuticals Inc., |
Modulatori metabolizma i lečenje poremećaja koji su vezi sa njima
|
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
|
CA2630714C
(en)
|
2005-11-23 |
2014-01-14 |
Epix Delaware, Inc. |
S1p receptor modulating compounds and use thereof
|
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
|
EP2386547B1
(en)
|
2005-12-29 |
2018-06-20 |
Lexicon Pharmaceuticals, Inc. |
Multicyclic amino acid derivatives and methods of their use
|
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
PL1973884T3
(pl)
|
2006-01-19 |
2017-05-31 |
Orchid Pharma Limited |
Nowe związki heterocykliczne
|
|
ATE447568T1
(de)
|
2006-01-24 |
2009-11-15 |
Actelion Pharmaceuticals Ltd |
Neue pyrinderivate
|
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
|
JP2009526073A
(ja)
|
2006-02-09 |
2009-07-16 |
ユニバーシティ オブ バージニア パテント ファンデーション |
二環式スフィンゴシン−１−リン酸受容体アナログ
|
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
EP1984334B1
(en)
|
2006-02-15 |
2014-04-09 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
JP2009527501A
(ja)
|
2006-02-21 |
2009-07-30 |
ユニバーシティ オブ バージニア パテント ファンデーション |
Ｓ１ｐ受容体アゴニストとしてのフェニル−シクロアルキル誘導体およびフェニル−複素環誘導体
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
WO2007106469A2
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
|
CL2007000742A1
(es)
|
2006-03-21 |
2008-01-11 |
Epix Delaware Inc |
Compuestos derivados de 2-oxoimidazol, moduladores del recptor s1p (esfingosina-1-fosfato); composicion farmceutica que los contiene; y su uso para tratar condiciones tales como rechazo de trasplante, cancer, artritis reumatoide y diabetes.
|
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
|
EP2003132B1
(en)
|
2006-04-03 |
2014-03-05 |
Astellas Pharma Inc. |
Oxadiazole derivatives as S1P1 agonists
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
SG10201404220TA
(en)
|
2006-04-11 |
2014-10-30 |
Arena Pharm Inc |
Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
|
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
|
JPWO2007129745A1
(ja)
|
2006-05-09 |
2009-09-17 |
第一三共株式会社 |
ヘテロアリールアミド低級カルボン酸誘導体
|
|
EP2021338A1
(en)
|
2006-05-09 |
2009-02-11 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
|
WO2007129473A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
二環性アリール誘導体
|
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
WO2008008887A2
(en)
|
2006-07-13 |
2008-01-17 |
Smithkline Beecham Corporation |
Gpr119 agonists for treating metabolic disorders
|
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
|
JP2009545597A
(ja)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
スフィンゴシン−１−ホスフェート受容体（ｓｌｐ）のアゴニスト
|
|
EP2099768A2
(en)
|
2006-08-04 |
2009-09-16 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine-1-phosphate receptor
|
|
MY152176A
(en)
|
2006-08-08 |
2014-08-15 |
Kyorin Seiyaku Kk |
Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
|
|
WO2008024196A1
(en)
|
2006-08-24 |
2008-02-28 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
CA2661371A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyrimidine compounds for treating gpr119 related disorders
|
|
PL2069336T3
(pl)
|
2006-09-07 |
2013-05-31 |
Idorsia Pharmaceuticals Ltd |
Pochodne pirydyn-4-ylu jako środki immunomodulujące
|
|
JP2010504286A
(ja)
|
2006-09-07 |
2010-02-12 |
アラーガン インコーポレイテッド |
スフィンゴシン−１−リン酸（ｓ１ｐ）受容体アゴニスト及び／又はアンタゴニスト生物活性を有するヘテロ芳香族化合物
|
|
TWI408139B
(zh)
|
2006-09-07 |
2013-09-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
|
JP2010502675A
(ja)
|
2006-09-08 |
2010-01-28 |
ノバルティス アクチエンゲゼルシャフト |
リンパ球相互作用が介在する疾患または障害を処置するために有用なｎ−ビアリール（ヘテロ）アリールスルホンアミド誘導体
|
|
CN101522645B
(zh)
|
2006-09-21 |
2013-01-09 |
埃科特莱茵药品有限公司 |
苯衍生物及其免疫调节剂的用途
|
|
KR20090097184A
(ko)
|
2006-12-06 |
2009-09-15 |
스미스클라인 비참 코포레이션 |
비시클릭 화합물 및 항당뇨병제로서의 용도
|
|
WO2008076243A2
(en)
|
2006-12-14 |
2008-06-26 |
Merck & Co., Inc. |
Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|
|
SG177221A1
(en)
|
2006-12-15 |
2012-01-30 |
Abbott Lab |
Novel oxadiazole compounds
|
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
|
JP2010513532A
(ja)
|
2006-12-21 |
2010-04-30 |
アボット・ラボラトリーズ |
スフィンゴシン−１−ホスフェート受容体作働薬および拮抗薬化合物
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
AU2008206495A1
(en)
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having Sphingosine-1-Phosphate (S1P) receptor antagonist biological activity
|
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2008114157A1
(en)
|
2007-03-16 |
2008-09-25 |
Actelion Pharmaceuticals Ltd |
Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
|
|
AU2007227278B2
(en)
|
2007-03-21 |
2014-09-11 |
Epix Pharmaceuticals, Inc. |
SIP receptor modulating compounds and use thereof
|
|
WO2008128832A1
(en)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
|
|
TWI408137B
(zh)
|
2007-04-19 |
2013-09-11 |
Glaxo Group Ltd |
經取代之二唑衍生物、其醫藥用途及醫藥組合物
|
|
PE20090222A1
(es)
|
2007-05-04 |
2009-03-27 |
Bristol Myers Squibb Co |
Compuestos [6,6] y [6,7]-biciclicos como agonistas del receptor acoplado a la proteina g gpr119
|
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
KR20100051849A
(ko)
|
2007-08-08 |
2010-05-18 |
메르크 세로노 에스. 에이. |
다발성 경화증의 치료를 위한 스핑고신-1-포스페이트(ｓ1ｐ)수용체에 결합하는 6-아미노-피리미딘-4-카르복스아미드 유도체 및 이와 관련된 화합물
|
|
CA2697551C
(en)
|
2007-09-20 |
2013-03-12 |
Irm Llc |
Piperidine derivatives as modulators of gpr119 activity
|
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
|
US20100273806A1
(en)
|
2007-12-18 |
2010-10-28 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
AU2009206733A1
(en)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists
|
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
|
LT2278960T
(lt)
|
2008-03-17 |
2017-02-10 |
Actelion Pharmaceuticals Ltd. |
S1p1 receptoriaus selektyvaus agonisto dozavimo režimas
|
|
MX2010011070A
(es)
|
2008-04-07 |
2011-01-20 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de gpr119.
|
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
|
WO2009125434A2
(en)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Oxime derivatives
|
|
US8796318B2
(en)
|
2008-05-14 |
2014-08-05 |
The Scripps Research Institute |
Modulators of sphingosine phosphate receptors
|
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
US8580841B2
(en)
*
|
2008-07-23 |
2013-11-12 |
Arena Pharmaceuticals, Inc. |
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
PL2342205T3
(pl)
*
|
2008-08-27 |
2016-12-30 |
|
Podstawione tricykliczne pochodne kwasowe jako antagoniści receptora S1P1 użyteczni w leczeniu zaburzeń autoimmunologicznych i zapalnych
|
|
CA2747992C
(en)
*
|
2008-12-22 |
2017-11-07 |
Novartis Ag |
Dosage regimen of an s1p receptor agonist
|
|
CN102264359A
(zh)
*
|
2008-12-22 |
2011-11-30 |
诺瓦提斯公司 |
S1p受体激动剂的给药方案
|
|
JP2012513470A
(ja)
|
2008-12-23 |
2012-06-14 |
シェーリング コーポレイション |
二環式複素環誘導体及びその使用方法
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010074271A1
(ja)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
TW201031668A
(en)
|
2009-01-22 |
2010-09-01 |
Mitsubishi Tanabe Pharma Corp |
Novel pyrrolo[2,3-d] pyrimidine compound
|
|
KR20110117706A
(ko)
|
2009-02-10 |
2011-10-27 |
아보트 러보러터리즈 |
Ｓ１ｐ5 수용체의 효능제 및 길항제, 및 이들의 사용 방법
|
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
|
WO2011030139A1
(en)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
|
|
KR20130036171A
(ko)
|
2009-10-29 |
2013-04-11 |
브리스톨-마이어스 스큅 컴퍼니 |
트리시클릭 헤테로시클릭 화합물
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
CN108558740B
(zh)
|
2010-01-27 |
2021-10-19 |
艾尼纳制药公司 |
S1p1受体调节剂及其盐的制备方法
|
|
EP2542554B1
(en)
|
2010-03-03 |
2015-11-04 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
|
|
WO2011127051A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2012015758A2
(en)
|
2010-07-30 |
2012-02-02 |
Saint Louis University |
Methods of treating pain
|
|
CA2812061A1
(en)
|
2010-09-22 |
2012-03-29 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
MY163274A
(en)
|
2011-02-07 |
2017-08-30 |
Biogen Ma Inc |
S1p modulating agents
|
|
WO2012135570A1
(en)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
KR101889131B1
(ko)
|
2011-12-23 |
2018-09-20 |
메이지 세이카 파루마 가부시키가이샤 |
신규 s1p 수용체 조정제
|
|
CA2900844C
(en)
|
2013-04-04 |
2022-05-03 |
Novartis Ag |
Identifying patient response to s1p receptor modulator administration
|
|
US11007175B2
(en)
|
2015-01-06 |
2021-05-18 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
KR102883123B1
(ko)
|
2015-06-22 |
2025-11-10 |
아레나 파마슈티칼스, 인크. |
Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
|
|
ES2981521T3
(es)
|
2017-02-16 |
2024-10-09 |
Arena Pharm Inc |
Compuestos y procedimientos para el tratamiento de la enfermedad inflamatoria intestinal con manifestaciones extraintestinales
|
|
MA47504A
(fr)
|
2017-02-16 |
2019-12-25 |
Arena Pharm Inc |
Composés et méthodes de traitement de l'angiocholite biliaire primitive
|
|
WO2019236757A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
WO2020072824A1
(en)
|
2018-10-03 |
2020-04-09 |
Arena Pharmaceuticals, Inc. |
Methods for the treatment of scleroderma
|
|
CN118649163A
(zh)
|
2018-11-30 |
2024-09-17 |
艾尼纳制药公司 |
治疗与s1p1受体有关的病况的方法
|
|
WO2020146529A1
(en)
|
2019-01-08 |
2020-07-16 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|